New research exposes how prompt injection in AI agent frameworks can lead to remote code execution. Learn how these ...
MicroStrategy (NASDAQ:MSTR) carries a consensus Hold rating and median price target of $130. The stock has shed 52% over the past year and sits 71% below its July 2025 peak of $457.22, yet analysts ...
Over the past year, decisions by the Trump administration have introduced a new level of instability into American life. New international tariffs disrupted the global trade market and raised ...
Office Scripts in Excel offer a structured way to automate repetitive tasks, making it easier to manage large datasets or streamline workflows. Built into the “Automate” tab of Excel’s ribbon, this ...
Space The AMOC moves closer to collapse, scientists create artificial neurons, the "Iliad" is found inside and Egyptian mummy, and researchers search for treatments for brain-eating amoebas Artificial ...
GameSpot may get a commission from retail offers. When Barbarian and Weapons director Zach Cregger signed on to helm the next Resident Evil movie, it was described as "a revamp that will take the ...
Morgan Pinder is a writer at GameRant and a graduate researcher at Deakin University in Australia. Their research interests are in video games, environmentalism and gothic media. Morgan’s most recent ...
Shares of billionaire Michael Saylor's Strategy (MSTR), a major Bitcoin holder, are among the most “heavily shorted” - a market term indicating strong bearish bets - according to data from FactSet and ...
There seems to be no stop for MicroStrategy's Bitcoin (BTC) shopping. Every week, there is at least one purchase. In fact, at press time, MicroStrategy, now better known as Strategy (NASDAQ: MSTR), ...
A Settlement, Not a Sigh of Relief: What the FTC’s Express Scripts Deal Signals for Enforcement Risk
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
“Too many women’s scripts never even get a read,” co-founder Jan Kimbrough says. “We exist to change that." By Kimberly Nordyke Managing Editor, Digital The Women’s List, a nonprofit organization ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results